The agency did not give further details about the individual. The patient is currently hospitalized and is in good health, the KDCA said. The individual had been experiencing symptoms since the end of March and had been in contact with others for several days. The individual also had no known contact with an infected person, it added. Unlike the previous five cases in the country, which were linked to overseas travel, the latest patient had not traveled abroad within the past three months, the KDCA said. Finally, he was nominated as President-elect of the Canadian Urology Association.The person visited a hospital Monday with a skin rash and was reported to health authorities as a suspected case of mpox, formerly known as monkeypox, reports Yonhap news agency. He is actively involved in a leadership role in national and provincial guidelines in prostate, bladder and testicular cancer surgery outcomes and has published over 230 peer-reviewed original scientific papers. He is a member of the Mashdots Foundation executive committee and serves as a reviewer for the Semerdjian Fund. He serves or has served on several Boards of Directors or executive committees, including the Rossy Cancer Network of McGill University, Cedars Cancer Foundation, Goodman Cancer Research Centre, MUHC-Research Institute, Canadian Urology Association, Bladder Cancer Canada, and Procure Alliance. In addition, in 2004 he was a founding member of Procure, a Quebec-based Prostate Cancer Foundation dedicated to research and public awareness. ![]() He has obtained independent peer-reviewed grants from several organizations including the US Department of Defense and the National Cancer Institute, and served as interim editor in chief of the Canadian Urology Association Journal. Aprikian has been awarded the American Society of Clinical Oncology Young Investigator Award, the American Urologic Association Practicing Urologist Award, the Canadian Urology Association Scholarship, the McGill University William Dawson Scholar Career Award and the Quebec FRSQ Senior Clinician Scientist Award. Finally, in 2020 he was appointed as Clinical Lead of McGill’s Rossy Cancer Network.ĭr. Moreover, in 2010 he was appointed the McGill University Richard Tomlinson Professor in Prostate Cancer. In 2007 he became Full Professor of Surgery and Oncology and in 2009 he was appointed the Medical Director of the MUHC Cancer Care Mission and Chief of the Department of Oncology. In 2004 he became the Head of the Division of Urology at McGill University and the Chief of Urology at the McGill University Health Centre (MUHC). In 1998 he became the McGill Division of Urology Training Program Director and in 2000 established the Annual Canadian Senior Resident Urologic Oncology Course which runs to this day. ![]() In 1993 he was appointed Assistant Professor of Surgery (Urology) at McGill University and began his career in prostate and bladder cancer research and as a clinical urologic oncologist. He then pursued a 3-year research and clinical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Centre in New York City. ![]() Armen Aprikian graduated from the University of Sherbrooke Medical School in Quebec in 1985 and completed his urology residency training at McGill University in 1990. Armen Aprikian is the Clinical Lead of McGill’s Rossy Cancer Network and is President-elect of the Canadian Urology Association.ĭr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |